The MAGEC spinal bracing and distraction system (Ellipse Technologies Inc.) is used in children aged 2 years or over to brace the spine during growth and minimise the progression of scoliosis. This is a Guidance Update of MTG18, following the Guidance Review decision of December 2019.
NICE is currently working to respond to the operational challenges posed to our normal work programmes. The stakeholders and advisory committees involved in the development of our guidance include a large number of frontline NHS staff. We know that their priority in this crisis is caring for patients and we do not want to draw them away from this vital work. For this reason, we are reviewing all of our guidance in development and will be prioritising only therapeutically critical topics at this time. Please accept our apologies for any disappointment this may cause. This is a rapidly changing situation and we will keep our approach under review. Our priority is to support the NHS to care for people during this difficult time. At present we’re not able to confirm the key dates for this guidance
 
Status Schedule affected by COVID-19
Process MT
ID number 169

Provisional Schedule

Resolution 03 August 2020
Expected publication 15 September 2020

Project Team

Project lead Neil Hewitt

Email enquiries

Stakeholders

External assessment group Newcastle upon Tyne Hospitals
Manufacturers NuVasive, Inc.
Professional groups Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Boston Scientific
  Department of Health and Social Care
  Devices for Dignity
  Greater Manchester Health & Social Care Partnership
  Healthcare Improvement Scotland
  HealthTech Alliance
  Johnson & Johnson Medical Ltd
  Medical Technology Group
  Medicines and Healthcare Products Regulatory Agency
  NHS England
  The British In Vitro Diagnostics Association (BIVDA)

Timeline

Key events during the development of the guidance:

Date Update
27 May 2020 Schedule affected by COVID-19. NICE is currently working to respond to the operational challenges posed to our normal work programmes. The stakeholders and advisory committees involved in the development of our guidance include a large number of frontline NHS staff. We know that their priority in this crisis is caring for patients and we do not want to draw them away from this vital work. For this reason, we are reviewing all of our guidance in development and will be prioritising only therapeutically critical topics at this time. Please accept our apologies for any disappointment this may cause. This is a rapidly changing situation and we will keep our approach under review. Our priority is to support the NHS to care for people during this difficult time. At present we’re not able to confirm the key dates for this guidance
24 April 2020 Committee meeting: 1
06 February 2020 Scope published

For further information on how we develop guidance, please see our page about NICE medical technologies guidance